In this analysis, Shah and colleagues examined a cohort of 1044 patients with scleroderma to identify factors that were associated with the presence of cancer and with a short cancer/scleroderma ...

SAN FRANCISCO, Dec 5, 2013 /PRNewswire-USNewswire/ -- The Scleroderma Research Foundation today reported that researchers at The Johns Hopkins University have discovered that some cases of scleroderma ...

Patients with a certain type of scleroderma may get cancer and scleroderma simultaneously, Johns Hopkins researchers have found, suggesting that in some diseases, autoimmunity and cancer may be linked ...

Sixteen years ago, a research group at Mayo Medical School published results showing that a protein called TRAIL can kill cells that cause liver fibrosis but no one seemed to follow up on these ...

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — There is a close temporal link between cancer and the onset of scleroderma in patients with ...

Scientists have found evidence that cancer triggers the autoimmune disease scleroderma, which causes thickening and hardening of the skin and widespread organ damage. Johns Hopkins scientists have ...

Included patients from the Johns Hopkins Scleroderma Center Research Registry and the University of Pittsburgh Scleroderma Center, Pittsburgh, Pennsylvania. A total of 676 patients with scleroderma ...

A protein known to play a role in cancer may also be increasing fibrosis in scleroderma patients. Scleroderma, a rare, chronic autoimmune disease, is marked by hardening of the skin and internal ...

Please provide your email address to receive an email when new articles are posted on . Cancer screening for high-risk patients with scleroderma should involve basic age, sex and risk factor targeted ...

An anti-cancer drug that suppresses the immune system is the first drug that has been shown to alleviate the most devastating effects of scleroderma, a disease of the connective tissues and lungs.

The chemotherapy drug paclitaxel, when given to mice, shows signs of impeding the skin disease scleroderma, researchers report. By slowing skin thickening, paclitaxel might offer a treatment for a ...

Johns Hopkins scientists have found evidence that cancer triggers the autoimmune disease scleroderma, which causes thickening and hardening of the skin and widespread organ damage. A report on the ...